Most healthcare mergers and acquisitions (M&A) professionals see a positive outlook for healthcare and life sciences deals next year, even as political uncertainty will be the biggest factor to upend transactions, according to a recent Merrill Insight poll of global M&A professionals.According to the poll, which included more than 200 respondents from the Americas and Europe, the Middle East and Africa (EMEA), 52% of respondents believe that the M&A market is headed in a positive
Read More
Brexit
MACRA, Brexit and the McDonaldization of Healthcare
MACRA seems to be the talk of the town right now. MACRA and MIPS and APM and the dozens of sub-acronyms flying around like so many arrows in this Game of Thrones, Battle of the Bastards. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) was signed into law over a year ago. That’s right, MACRA is the “law of the land” now, and it became law of the land with overwhelming bipartisan support in Congress and with much lobbying and cheerleading from medical associations. MACRA is not a
Read More
